Human FGF2/BFGF/FGF-2 ORF/cDNA clone-Lentivirus plasmid (NM_002006)
Cat. No.: pGMLV000801
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human FGF2/BFGF/FGF-2 Lentiviral expression plasmid for FGF2 lentivirus packaging, FGF2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
FGF2/BFGF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
Catalog ID | pGMLV000801 |
Gene Name | FGF2 |
Accession Number | NM_002006 |
Gene ID | 2247 |
Species | Human |
Product Type | Lentivirus plasmid (overexpression) |
Insert Length | 867 bp |
Gene Alias | BFGF,FGF-2,FGFB,HBGF-2 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Biosimilar | GMP-Bios-INN-820 | Pre-Made Eflimrufusp Alfa Biosimilar, Fusion Protein targeting FGF2 fused with human IGHG1 Fc (Fragment constant): Recombinant therapeutic protein targeting BFGF/FGF-2/FGFB/HBGF-2 |
Biosimilar | GMP-Bios-INN-969 | Pre-Made Recifercept biosimilar, Recombinant Protein: Recombinant therapeutic protein targeting FGF |
Target Antibody | GM-Tg-g-T31621-Ab | Anti-FGF2/ BFGF/ FGF-2 functional antibody |
Target Antigen | GM-Tg-g-T31621-Ag | FGF2 protein |
Cytokine | cks-Tg-g-GM-T31621 | fibroblast growth factor 2 (basic) (FGF2) protein & antibody |
ORF Viral Vector | pGMLV000801 | Human FGF2 Lentivirus plasmid |
ORF Viral Vector | pGMAD000136 | Human FGF2 Adenovirus plasmid |
ORF Viral Vector | vGMLV000801 | Human FGF2 Lentivirus particle |
ORF Viral Vector | vGMAD000136 | Human FGF2 Adenovirus particle |
Target information
Target ID | GM-T31621 |
Target Name | FGF2 |
Gene ID | 2247, 14173, 574136, 54250, 100135772, 403857, 281161, 100033955 |
Gene Symbol and Synonyms | BFGF,FGF-2,FGF2,Fgf2a,FGFB,HBGF-2 |
Uniprot Accession | P09038 |
Uniprot Entry Name | FGF2_HUMAN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, Immuno-oncology Target, INN Index, Cytokine Target |
Disease | Breast Cancer |
Gene Ensembl | ENSG00000138685 |
Target Classification | Checkpoint-Immuno Oncology |
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.